'It is not going away': Virologist fund manager Dr Ogden discusses all things coronavirus

Single vaccine 'not enough' to treat patients

Lauren Mason
clock • 7 min read

The coronavirus pandemic has changed how the world's healthcare systems and biotechnology companies will operate irrevocably as Covid-19 "isn’t going to go away", according to virologist and manager of the AUS$335m Platinum International Healthcare fund Dr Bianca Ogden.

Ogden, who obtained a PhD in virology, and previously worked as a scientist for Johnson & Johnson and Novartis before launching the portfolio in 2003, said comparisons can be made between the Covid-19 strain of the coronavirus and HIV, in that it cannot be eradicated via a single vaccine. "When you look at the family of coronaviruses, they don't tend to go away. They were compared relatively early on to the HIV virus; it is a different family, but similarly it is something we will have to live with, and it means we will have to adjust how we live," she explained. "Coronaviruses have b...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

NextWealth MD Hopkins on staying ahead of advice sector changes, data challenges and flattening MPS fees

NextWealth MD Hopkins on staying ahead of advice sector changes, data challenges and flattening MPS fees

Making technology work better

Katrina Lloyd
clock 03 July 2025 • 9 min read
IFAs look to boost clients' private markets exposure

IFAs look to boost clients' private markets exposure

Expect increase in stock market volatility

Jen Frost
clock 02 July 2025 • 2 min read
Winds of change: Private markets access for retail investors

Winds of change: Private markets access for retail investors

Investing in LTAFs, accessibility aside, needs careful consideration

Dorian Hughes
clock 02 July 2025 • 5 min read